554 Sirolimus Gel Effectively Reduced Neurofibromas in Neurofibromatosis Type 1 in a Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of Investigative Dermatology- United Kingdom

doi 10.1016/j.jid.2019.03.630

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

May 1, 2019

Authors

M. Wataya-Kaneda

Publisher

Elsevier BV

Related search

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

Gastroenterology

Gastroenterology

English

Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial

Internal Medicine

Specialized Nursing

English

Double-Blind, Randomized Placebo-Controlled Clinical Trial of Benfotiamine for Severe Alcohol Dependence

Drug and Alcohol Dependence

English

Efficacy of Sodium Butyrate Adjunct Therapy in Shigellosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BMC Infectious Diseases

Infectious Diseases

English

Anastrozole in Pulmonary Arterial Hypertension (AIPH): A Randomized, Double-Blind Placebo-Controlled Trial

American Journal of Respiratory and Critical Care Medicine

Respiratory Medicine

Intensive Care Medicine

English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

English

A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression

Psychopharmacology

English

A Randomized Double-Blind Placebo-Controlled Trial of Probiotics in Post-Surgical Colorectal Cancer

BMC Gastroenterology

Gastroenterology

English

CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Annals of the Rheumatic Diseases

Molecular Biology

English